Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Jende van Zeben"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Manuel Castro Cabezas, Benjamin Burggraaf, Boudewijn Klop, Noelle van der Meulen, Lenneke Prinzen, Marijke A. de Vries, Erwin Birnie, Deborah F. van Breukelen-van der Stoep, Gert-Jan M van de Geijn, Jende van Zeben
Publikováno v:
Atherosclerosis. 271
BACKGROUND AND AIMS Rheumatoid arthritis (RA) has been associated with an increased risk of atherosclerosis. We aimed to evaluate the progression of carotid intima media thickness (cIMT) in RA patients subject to a cardiovascular treat-to-target inte
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ddb116c9b7f909dc93b25167bcc16950
https://pubmed.ncbi.nlm.nih.gov/29482038
https://pubmed.ncbi.nlm.nih.gov/29482038
Autor:
Manuel Castro Cabezas, Deborah F. van Breukelen-van der Stoep, Noelle van der Meulen, José Rioja Villodres, Gert-Jan M van de Geijn, Ellen van der Zwan, Jende van Zeben, José Ramírez-Bollero, Anho Liem, Pedro Valdivielso, Benjamin Burggraaf
Publikováno v:
European journal of clinical investigation. 48(2)
BACKGROUND Levels of apolipoprotein (apo) B48 may be increased in conditions associated with systemic inflammation and increased cardiovascular disease (CVD) risk such as rheumatoid arthritis (RA). We aimed to evaluate apo B48 levels in patients with
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d448479f500869c65597de13d1e97c10
https://pubmed.ncbi.nlm.nih.gov/29231984
https://pubmed.ncbi.nlm.nih.gov/29231984
Publikováno v:
BMJ Case Reports, 2018:bcr-2017-223206. BMJ Publishing Group
A 66-year-old man with seronegative, erosive rheumatoid arthritis for 12 years presented with malaise, elevated alkaline phosphatase and gamma-glutamyl transferase, and leg oedema. He subsequently developed ascites. No liver pathology was found, but
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::92373fdd625b6332d447f47410a37855
https://doi.org/10.1136/bcr-2017-223206
https://doi.org/10.1136/bcr-2017-223206
Autor:
Marijke A. de Vries, Noelle van der Meulen, Manuel Castro Cabezas, Gert-Jan Van Der Geijn, Jende van Zeben, Benjamin Burggraaf, Deborah Van Breukelen, Lenneke Prinzen
Publikováno v:
Atherosclerosis. 263:e97
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a0e1fa45504e051b6f8a5b17e8906d43
https://doi.org/10.1016/j.atherosclerosis.2017.06.315
https://doi.org/10.1016/j.atherosclerosis.2017.06.315
Autor:
Henk C. Van Paassen, Eric-Jan Kroot, Jacques M.G.W. Wouters, A. Margriet Huisman, Jende van Zeben
Publikováno v:
Annals of the New York Academy of Sciences. 1069
Pulse therapy with high-dose glucocorticoids (GCs) is widely used as "bridging therapy" for the treatment of patients with active rheumatoid arthritis (RA). Oral pulsed dexamethasone therapy has never been used for this purpose. We determined the cli
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::41f4d71d5cbeb7ffa27606a2d1b1875e
https://pubmed.ncbi.nlm.nih.gov/16855157
https://pubmed.ncbi.nlm.nih.gov/16855157
Publikováno v:
The Journal of Rheumatology. 36:2847-2848
To the Editor: Anti-tumor necrosis factor (TNF)-α agents such as infliximab, adalimumab, and etanercept are more and more widely used. With this we see a growing number of case reports describing adverse events that occur during anti-TNF-α therapy.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::da5ed2dafc4d0611864ce969978b6b6e
https://doi.org/10.3899/jrheum.090307
https://doi.org/10.3899/jrheum.090307
Autor:
Jacques M.G.W. Wouters, Deborah F. Van Der Stoep, Vincent Noordhoek Hegt, Gert Jan Braunstahl, Jende van Zeben
Publikováno v:
European Journal of Internal Medicine. 20:S148
fell significantly with treatment over the 6 months period. (p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9aac14d090f7d36116994768c7dca302
https://doi.org/10.1016/s0953-6205(09)60457-x
https://doi.org/10.1016/s0953-6205(09)60457-x